Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Well to 'review' Lloydspharmacies for sale, and won't close own stores

Well Pharmacy will "review" the list of 190 Lloydspharmacy branches when they come up for sale, and has no plans to close stores of its own, C+D has learned.

Lloydspharmacy parent company Celesio UK announced last week (October 26) it will cease trading in 190 “commercially unviable” branches across England, “through a combination of store closures and divestments”.

It exclusively told C+D it is “already in discussions with some parties who have expressed an interest in our pharmacies”, but was unable to confirm which branches it has identified for sale.

Well Pharmacy chief executive John Nuttall told C+D it is “not actively involved in these discussions”.

“However, once more information and a store list is made available, our portfolio team will review it,” Mr Nuttall said last Friday (October 27).

Well is “taking a different approach” in response to the funding pressures in England, Mr Nuttall added, “by investing in our hub-and-spoke model and digital operations”.

“Our thoughts go out to all the colleagues and communities potentially impacted by [the Lloydspharmacy announcement],” he stressed.

“No plans” for Well closures

Mr Nuttall also sent a message to all Well employees “reassuring” them the chain “has a strong plan” for the future, “and has no plans to close any pharmacies”.

See a full copy of Mr Nuttall’s announcement to Well employees below.

Dear colleagues,

You will have seen in the news that Lloydspharmacy have announced they will be ceasing trade in 190 pharmacies across England.

As a result of this news, I wanted to write to you and reassure you that we have a strong plan for Well, and have no plans to close any pharmacies. Personally, I am confident of our future, there is no question we are going through a big shake up in the industry.

Our priorities for the 17-18 financial year remain unchanged. The pressure continues to increase for our pharmacy teams and the sector as a whole. We’ve been really honest with everyone about our plans to transform how we work. We will be automating how we manage our repeat prescriptions through advanced dispensing, to get us ahead of the competition.

I’ve witnessed first-hand your resilience and determination and it is more important than ever to consistently focus on our customers, making sure every patient who walks into our pharmacies feels the care and empathy they deserve.

While I am very confident in our future, it matters to me how you feel and that you share my confidence in this business. Our potential is enormous. Some of the work we are leading should change the landscape of the profession and pharmacy market.

I know it has been a tough year, and it will continue to be challenging. I truly believe we are well positioned in the marketplace to take advantage of the opportunities this change brings, and that you have the passion and ability to deliver outstanding service for our customers.

Kind regards, 

John Nuttall
Chief executive

Are you a Lloydspharmacy employee?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD009020

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel